Lung Cancer News

FDA announced the creation of a voluntary pilot program that will assist clinicians in selecting the appropriate treatment for patients with cancer through the use of laboratory-developed tests, according to an FDA press release.

Alectinib appeared less effective among patients with lung cancer when taken with low-fat yogurt compared with a fuller breakfast or lunch, according to data published in Journal of the National Comprehensive Cancer Network.

CHICAGO — Patients with advanced non-small cell lung cancer who tested positive for biomarkers and subsequently received guideline-recommended treatment had better outcomes, according to research presented at ASCO Annual Meeting.

American Society for Radiation Oncology, in collaboration with European Society for Radiotherapy and Oncology, has issued a guideline on use of definitive local therapy for patients with oligometastatic non-small cell lung cancer.

CHICAGO — Long-term follow up shows that response to tepotinib remains robust in patients with MET exon-14 skipping non-small cell lung cancer, according to research presented at ASCO Annual Meeting.

CHICAGO — An electronic frailty index may help to predict risk for poor outcomes, including mortality, in patients undergoing chemotherapy.

CHICAGO — Healio spoke with Karen L. Reckamp, MD, on updated findings from the ADAURA trial presented at ASCO Annual Meeting.

CHICAGO — Patients diagnosed with stage IV non-small cell lung cancer who received a tyrosine kinase inhibitor following clinical molecular testing had better OS, according to research presented at ASCO Annual Meeting.

ASCO Chief Medical Officer Julie R. Gralow, MD, FACP, FASCO, urged members of Congress to take action on cancer drug shortages, which she described as the worst she has witnessed during her 30-year career in oncology.

CHICAGO — Healio | HemOnc Today gathered the best, brightest and boldest in oncology for its second annual Disruptive Innovators Awards.